Development and evaluation of a new IgM/IgG rapid diagnostic test for SARS-CoV-2
View ORCID ProfileP.J. Ducrest
doi: https://doi.org/10.1101/2020.10.09.20209866
P.J. Ducrest
1GaDia SA, Route de l’ile au bois 1A, 1870 Monthey, Switzerland

- Supplementary material[supplements/209866_file02.pdf]
Posted October 13, 2020.
Development and evaluation of a new IgM/IgG rapid diagnostic test for SARS-CoV-2
P.J. Ducrest
medRxiv 2020.10.09.20209866; doi: https://doi.org/10.1101/2020.10.09.20209866
Subject Area
Subject Areas
- Addiction Medicine (62)
- Allergy and Immunology (142)
- Anesthesia (46)
- Cardiovascular Medicine (415)
- Dermatology (47)
- Emergency Medicine (144)
- Epidemiology (4857)
- Gastroenterology (183)
- Geriatric Medicine (70)
- Health Economics (192)
- Health Informatics (630)
- Health Policy (320)
- Hematology (85)
- HIV/AIDS (156)
- Medical Education (93)
- Medical Ethics (24)
- Nephrology (75)
- Neurology (686)
- Nursing (42)
- Nutrition (115)
- Oncology (439)
- Ophthalmology (140)
- Orthopedics (36)
- Otolaryngology (89)
- Pain Medicine (35)
- Palliative Medicine (16)
- Pathology (129)
- Pediatrics (194)
- Public and Global Health (1816)
- Radiology and Imaging (324)
- Respiratory Medicine (255)
- Rheumatology (86)
- Sports Medicine (62)
- Surgery (100)
- Toxicology (23)
- Transplantation (29)
- Urology (37)